Page last updated: 2024-09-04

abiraterone and morphinans

abiraterone has been researched along with morphinans in 1 studies

Compound Research Comparison

Studies (abiraterone)	Trials (abiraterone)	Recent Studies (post-2010) (abiraterone)	Studies (morphinans)	Trials (morphinans)	Recent Studies (post-2010) (morphinans)
942	97	854	3,251	307	648

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Antonarakis, ES; Carducci, MA; Chen, Y; De Marzo, AM; Denmeade, SR; Eisenberger, MA; Fedor, HL; Isaacs, JT; Isaacs, WB; Lotan, TL; Lu, C; Luber, B; Luo, J; Mohammad, TA; Nadal, R; Nakazawa, M; Paller, CJ; Roeser, JC; Wang, H; Zheng, Q	1

Other Studies

1 other study(ies) available for abiraterone and morphinans

Article	Year
AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer. The New England journal of medicine, 2014, Sep-11, Volume: 371, Issue:11 Topics: Androstenes; Androstenols; Benzamides; Drug Resistance, Neoplasm; Humans; Male; Morphinans; Nitriles; Phenylthiohydantoin; Prostatic Neoplasms; Receptors, Androgen; Reverse Transcriptase Polymerase Chain Reaction; RNA, Neoplasm; Survival Analysis	2014

Article

Year

AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer.

The New England journal of medicine, 2014, Sep-11, Volume: 371, Issue:11

Topics: Androstenes; Androstenols; Benzamides; Drug Resistance, Neoplasm; Humans; Male; Morphinans; Nitriles; Phenylthiohydantoin; Prostatic Neoplasms; Receptors, Androgen; Reverse Transcriptase Polymerase Chain Reaction; RNA, Neoplasm; Survival Analysis

2014